Since 2000, Advanced Targeting Systems has presented an award each year at the Society for Neuroscience meeting for the best Poster of the Year using ATS targeting tools. This year the competition was fierce and some very exciting science was presented.
Also, a big congratulations to the winner of the drawing for a $500 product credit: Melissa Edler from Northeast Ohio Medical University in Rootstown, Ohio USA!
Read on to view this year’s contenders and the 2017 Poster of the Year award winner.
The runners-up this year were:
- Daniel Hulsey from University of Texas, Richardson, Texas USA used Anti-DBH-SAP (Cat. #IT-03) entitled:
Vagus nerve stimulation dependent enhancement of motor cortex plasticity requires noradrenergic innervation
- Kristen Horner from Mercer University in Macon, Georgia USA used Dermorphin-SAP (Cat. #IT-12) entitled:
Patch compartment lesions reduce habitual sucrose consumption
- Sally Krajewski-Hall from University of Arizona, Tucson, Arizona USA used NK3-SAP (Cat. # IT-63) entitled:
Increased core temperature following ablation of neurokinin 3 receptor-expressing neurons in the mouse median preoptic nucleus and adjacent preoptic area (MnPO/POA)
- Andrea Suarez from USC in Los Angeles, California USA used CCK-SAP (Cat. #IT-31) entitled:
Gastrointestinal vagal afferent signaling promotes hippocampal-dependent memory function in rats
And the winner is . . .
Luiz Oliveira from University of Sao Paulo in Brazil used Orexin-B-SAP (Cat. #IT-20) entitled:
Role of orexinergic neurons in the chemosensory control of breathing in a Parkinson’s disease model
The orexin 1 and orexin 2 receptors are found in the perifornical area/latero-posterior hypothalamus, and projections from this area cover much of the brain. These receptors have been implicated in various neurophysiological and neuropsychological disorders such as narcolepsy, insomnia, drug addiction, anxiety, and migraine headaches. The orexin-B-SAP conjugate consists of the rat/mouse orexin-B peptide conjugated to saporin. Orexin-B binds to the orexin-2 receptor with approximately 5X greater affinity than to the orexin-1 receptor.